Get an alert when PFIZER LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-08-31 (in 3mo)

Last filed for 2024-11-30

Confirmation statement due

2026-07-13 (in 2mo)

Last made up 2025-06-29

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£2B

+66.7% vs 2023

Employees

1,243

-0.1% vs 2023

Profit before tax

£554M

+229% vs 2023

Accounts

2-year trend · latest reflected 2024-11-30

Metric Trend 2023-11-302024-11-30
Turnover £1,158,133,000£552,829,000
Operating profit £75,740,000£34,986,000
Profit before tax £168,483,000£554,263,000
Net profit £133,044,000£551,149,000
Cash
Total assets less current liabilities £865,055,000£1,399,450,000
Net assets £899,964,000£1,500,370,000
Equity £899,964,000£1,500,370,000
Average employees 1,2441,243
Wages £64,682,000£90,618,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-11-302024-11-30
Operating margin 6.5%6.3%
Net margin 11.5%99.7%
Return on capital employed 8.8%2.5%
Gearing (liabilities / total assets) 36.1%26.5%
Current ratio 2.33x2.97x
Interest cover 156.81x8.87x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
KPMG LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Based on these considerations, the directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”

Group structure

  1. PFIZER LIMITED · parent
    1. Neusentis Limited 100% · UK
    2. John Wyeth & Brother Ltd 100% · United Kingdom
    3. Wyeth Pharmaceuticals Limited 100% · Ireland
    4. PHIVCO Holdco Sarl 100% · Luxembourg
    5. PZR Ltd 100% · UK
    6. PZR Property Limited 100% · UK
    7. Hospira UK Limited 100% · United Kingdom
    8. Global Blood Therapeutics UK Limited 100% · United Kingdom
    9. Hospira Aseptic Services Limited 100% · United Kingdom
    10. Seagen UK Limited 100% · United Kingdom

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

7 active · 85 resigned

Name Role Appointed Born Nationality
HIGHTON, David Ian Director 2022-06-23 Jul 1968 British
MCGINLEY, John, Dr Director 2024-10-11 Dec 1976 Irish
NIJHER, Gurjinder Monica Kaur, Dr Director 2026-04-09 Jan 1977 British
PATTENDEN, Adam Edward Director 2025-04-23 Oct 1975 British
PEARSON, Edwin James Director 2017-01-09 Jan 1974 British
PHILLIPS, Berkeley Simon, Dr Director 2012-10-26 Jul 1969 British
SAINSBURY, Sarah Louise Director 2024-05-01 Aug 1971 British
Show 85 resigned officers
Name Role Appointed Resigned
HORTON, David Jeremy Secretary 1995-12-15
MOUNT, Jacqueline Ann Secretary 2012-02-01 2021-01-21
SUMNER, Matthew James Secretary 2004-02-06 2012-01-13
THOMAS, Robert Hugh, Dr Secretary 1996-11-15 2004-02-06
ZANANIRI, Francis Anthony Secretary 1995-12-15 1996-10-11
ALDENHOVEN, Clive Paul Director 1992-09-30
AUDLEY, Tony George Robert Director 1994-12-01 2004-05-31
BAUMAN, Eric Director 2005-04-28 2006-02-02
BENTLEY, Timothy Director 1994-12-01 2001-05-31
BEVAN, David Gower Director 2009-04-20 2013-04-19
BLACKBURN, Richard Neville Director 2009-02-09 2012-01-01
BRANDICOURT, Olivier Raymond Director 2003-04-30 2007-02-01
BROWNING, Richard Charles Director 1997-06-27 1999-04-08
CALDINI, Peter Director 2015-02-25 2016-05-15
CAMPBELL, Simon Fraser, Dr Director 1996-12-20 1998-09-30
COE, Peter Charles Director 1995-04-03 2001-11-30
COLES, Ruth Amy Director 2011-04-13 2015-07-24
CROW, Richard John Director 1996-10-22
DAY, Robert Michael Director 2015-04-22 2016-07-19
DAY, Robert Michael Director 2009-04-20 2012-10-11
DOHERTY, Annette Marian Director 2011-07-15 2012-07-31
DOHERTY, Annette Marian Director 2003-08-08 2009-03-26
DOLAN, Thomas Francis Director 2012-10-26 2016-12-31
DOOGAN, Declan Patrick, Dr Director 2001-05-01 2003-08-05
DOOGAN, Declan Patrick, Dr Director 1991-12-20 1995-03-17
DUNCAN, Greg Director 1997-07-01 1999-04-08
DUNNING, Anthony Alister Director 1998-04-30
EATON, James Andrew Director 2005-10-27 2008-01-15
ECCLES, Stella Director 2002-08-16 2006-07-31
EDWARDS, Geoffrey Mansel Director 1993-07-01 1997-03-13
EMBLING, John Clyde Director 2008-01-10 2010-03-08
EMMS, Jonathan Charles Director 2012-01-01 2015-01-31
FAUERBACH, Michael Director 2006-04-20 2009-02-28
FLETCHER, Karolyn Director 2000-02-07 2009-02-12
FLETCHER, Karolyn Director 1998-05-01 1999-04-08
FRANKLIN, Ian Eric Director 2008-11-01 2021-02-09
GILL, Imogen Director 2010-03-05 2012-11-06
GREENFIELD, Elizabeth Mary Director 2012-10-26 2018-04-30
HALL, Michael Christopher Director 1999-04-08
HANLEY, John Martin Director 2010-03-05 2013-04-16
HARNETT, Denise Jean Director 2018-04-26 2024-05-01
HUGHES, Darius Bruce Director 2014-02-05 2016-07-19
JOHNSON, Carole Anne Director 2016-02-12 2017-03-17
JONES, Maurice Ernest Director 2002-06-30
KNIGHT, Susan Pernille Director 2012-02-01 2012-05-03
LISSAMAN, John Director 1994-11-25
MARSHALL, George Arthur Director 1993-12-01 1996-01-28
MARSHALL, Vaila Mackenzie Director 2002-08-07 2003-06-06
MASTIN, Charles Norman Director 1993-10-05
MCDOWALL, Ewan John Director 2013-07-04 2014-02-07
MCGIBNEY, David, Doctor Director 1996-12-20 2001-03-01
MCKERNAN, Ruth Mitchell Director 2010-09-17 2015-04-10
MORAN, Kenneth James Director 1996-03-22 1999-12-31
MOUNT, Jacqueline Ann Director 2021-01-21 2022-05-31
NORDKAMP, Hendrikus Hermannus Director 2015-02-25 2020-11-16
NOSEWORTHY, Darren Director 2015-07-24 2017-01-09
O'CONNOR, William Hugh Director 1996-03-22
OSBORN, Ben Director 2018-11-05 2022-04-29
OSBORN, Benjamin John Director 2012-10-26 2015-04-22
OVERTOOM, Franciscus Johannes Carolus Director 2004-04-22 2008-11-01
PACKARD, Robert Spencer Director 1991-12-31
POULTON, Steven Michael Director 2009-04-20 2013-01-07
REYNOLDS, David Stuart, Dr Director 2015-04-22 2016-03-03
RICHARDSON, Scott Director 2017-02-09 2018-03-14
RIENOW, Susan Director 2022-02-28 2024-10-08
RIENOW, Susan Director 2018-03-23 2019-02-05
RINGROSE, Peter Stuart, Dr Director 1992-12-18 1996-11-25
ROBINSON, Ivar Director 2000-02-07 2002-02-05
ROBLIN, David, Dr Director 2009-02-09 2010-08-09
ROSE, Paul Richard Director 2019-02-06 2020-04-26
SELLER, Colin Malcolm Director 2017-04-27 2019-09-23
SELLER, Colin Malcolm Director 2006-08-01 2016-02-12
SMITH, John Richard Director 2012-02-01 2015-02-25
SMITH, Roger Llewellyn Director 2019-10-10 2025-04-24
STONE, Roger Director 2002-05-20 2005-09-20
THOMPSON, Julian Keith, Dr Director 2016-12-31 2025-02-21
TIIVOLA, Timo Rolf Juhani Director 2001-06-29 2002-12-20
TULLY, Paula Director 2013-02-07 2017-02-16
WALLCRAFT, Susan Jean Director 2009-02-09 2011-04-06
WHITEHEAD, Anthony Martin, Dr Director 1995-04-03 1999-04-08
WICKS, Stephen Richard Director 2009-02-09 2010-03-31
WILSON, Alan Brian Director 1992-11-09
WILSON, Michael John Director 1993-07-01 1999-04-07
WILSON, William John Director 1995-04-03
YOUNG, John Douglas Director 2007-02-07 2009-04-17

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Pfizer Inc Corporate entity Shares 75–100%, Voting 75–100% 2017-04-06 Active

Filing timeline

Last 20 of 315 total filings

Date Type Category Description
2026-04-22 AP01 officers Appoint person director company with name date PDF
2025-08-29 AA accounts Accounts with accounts type full
2025-07-07 CS01 confirmation-statement Confirmation statement with updates PDF
2025-05-08 AP01 officers Appoint person director company with name date PDF
2025-04-24 TM01 officers Termination director company with name termination date PDF
2025-02-24 TM01 officers Termination director company with name termination date PDF
2024-10-14 AP01 officers Appoint person director company with name date PDF
2024-10-08 TM01 officers Termination director company with name termination date PDF
2024-08-29 AA accounts Accounts with accounts type full
2024-07-10 CS01 confirmation-statement Confirmation statement with updates PDF
2024-05-10 AP01 officers Appoint person director company with name date PDF
2024-05-09 TM01 officers Termination director company with name termination date PDF
2024-05-03 SH01 capital Capital allotment shares PDF
2023-08-22 AA accounts Accounts with accounts type full
2023-07-11 CS01 confirmation-statement Confirmation statement with updates PDF
2022-08-09 AA accounts Accounts with accounts type full
2022-07-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-06-23 AP01 officers Appoint person director company with name date PDF
2022-05-31 TM01 officers Termination director company with name termination date PDF
2022-05-05 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
1

last 24 months

Officers appointed
1

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-11-30 vs 2023-11-30

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page